Idofnib 150 Soft Gelatin Capsule
Marketer
Lupin Ltd
Salt Composition
Nintedanib (150mg)
Overview Idofnib 150 Soft Gelatin Capsule
Nifidone 150mg softgel capsules are indicated for idiopathic pulmonary fibrosis and non-small cell lung carcinoma. This medication functions by inhibiting specific cellular pathways crucial to disease progression, thereby hindering or slowing the proliferation of cancerous cells. Administer Nifidone 150mg softgels with food, consistently at the same time each day for optimal efficacy. Dosage frequency and strength will be determined by your physician based on your condition and may be adjusted. Adhere strictly to your prescribed regimen; incorrect usage or overdosage can lead to severe adverse reactions. Therapeutic effects may not be evident immediately; continue treatment unless instructed otherwise by your doctor. Diarrhea is a frequent adverse event; maintain adequate hydration and consult your doctor if it persists. Additional common side effects comprise nausea, abdominal discomfort, emesis, atypical liver enzyme levels, anorexia, cephalalgia, weight reduction, and hypertension. Hepatic function monitoring through blood tests may be required. Prior to commencement, disclose any bleeding disorders, hepatic or renal impairments, or concomitant use of antimicrobial agents. Inform your healthcare provider of all medications, as interactions are possible. This medication is contraindicated during gestation and lactation. Reliable contraception is essential for both partners throughout the treatment period to prevent conception.
Uses of Idofnib 150 Soft Gelatin Capsule
Managing idiopathic pulmonary fibrosis and non-small cell lung cancer.
Major Benefits of Idofnib 150 Soft Gelatin Capsule:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Ingest the entire capsule; refrain from chewing, crushing, or breaking it. The Idofnib 150mg softgel should be administered with a meal.
Common Side effects of Idofnib 150 Soft Gelatin Capsule:
- Diarrhea
- Nausea
- Abdominal pain
- Vomiting
- Abnormal liver function tests
- Loss of appetite
- Headache
- Weight loss
- High blood pressure
How to use Idofnib 150 Soft Gelatin Capsule:
Consume this medication according to your physician's prescribed dosage and timeframe. Ingest the entire capsule; avoid crushing, chewing, or breaking it. The Idofnib 150 mg softgel should be administered with a meal.
How Idofnib 150 Soft Gelatin Capsule works:
Idofnib 150 mg softgel capsules are prescribed for cancer treatment. Their mechanism involves inhibiting an aberrant protein responsible for cancer cell proliferation. Concurrently, they suppress fibrotic pathways, reducing tissue thickening and scarring. This dual action contributes to cancer growth inhibition or retardation.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Idofnib 150 Soft Gelatin Capsules may pose safety risks; physician consultation is advised.
PregnancyCONSULT YOUR DOCTOR
Using Idofnib 150 Soft Gelatin Capsules during pregnancy poses a confirmed risk to the fetus. Therefore, it's unsafe. Nevertheless, a physician might exceptionally prescribe it in critical circumstances where the potential advantages outweigh the hazards. Always seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The use of Idofnib 150 mg soft gelatin capsules while breastfeeding is likely unsafe. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Taking Idofnib 150 Soft Gelatin Capsules might lead to adverse effects impairing your driving ability. Nausea is a potential side effect that could compromise safe driving.
KidneyCAUTION
Patients with severe kidney impairment should use Idofnib 150 mg soft gelatin capsules cautiously. Dosage modification may be necessary; physician consultation is advised. Data regarding Idofnib 150 mg soft gelatin capsule use in such patients is scarce.
LiverCAUTION
Patients with liver impairment should exercise caution when using Idofnib 150 mg soft gelatin capsules; dosage modification may be necessary. Consult your physician. Idofnib 150 mg soft gelatin capsules are contraindicated in individuals with moderate to severe hepatic dysfunction.
What if you forget to take Idofnib 150 Soft Gelatin Capsule :
Omit any missed Idofnib 150 mg softgel; resume your regular dosing regimen. Avoid taking a double dose.
Facts to Know About Idofnib 150 Soft Gelatin Capsule
| Label | Value |
|---|---|
| Chemical Category | Indole-carboxylic acids |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
| Actions | TKIs (Tyrosine Kinase Inhibitors) |
3,018 People bought this recently